XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds, Authority Hl7

42,405 resources

By Version

R2: 0
R2B: 0
R3: 2,217
R4: 26,023
R4B: 2,734
R5: 11,207
R6: 224

By Realm

none: 3,411
au: 272
be: 387
ca: 138
ch: 1,482
cl: 469
cr: 45
cz: 384
de: 190
dk: 88
ee: 155
eu: 1,173
fi: 87
fr: 120
in: 29
it: 181
kr: 5
nl: 929
no: 26
nz: 79
pl: 83
se: 22
stt: 116
us: 17,481
uv: 14,773
vn: 107
other: 7

Start Prev Rows 29600 - 29800 Next

Package	Version	Identity	Name/Title	Status	Date	Realm
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.10.20.5.9.21	NHSNReportNoEventsMDRO	active	2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.10.20.5.9.22	NHSNReportNoEventsDialysis	active	2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.10.20.5.9.24	NHSNVascularSpecimenCollectionSite	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.10.20.5.9.29	NHSNSSIDetectionMethod	active	2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.10.20.5.9.3	NHSNLastLocationEncounterTypeCode	active	2020-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.10.20.5.9.30	NHSNLOS/MENDischargeDisposition	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.10.20.5.9.31	NHSNSSIDetectionMethodType	active	2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.10.20.5.9.32	Codes for Outpatient Procedure Component Same Day Outcome Measures Summary Data	active	2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.10.20.5.9.33	NHSNReportNoEventsOPCSameDayOutcomeMeasures	active	2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.10.20.5.9.34	NHSNOPCProcedureCategoryCode	active	2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.10.20.5.9.35	NHSNReportNoEventsAR	active	2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.10.20.5.9.4	NHSNDrugSusceptibilityTestMethod	active	2020-04	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.10.20.5.9.40	NHSN COVID19 Case Classification	active	2021-04	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.10.20.5.9.5	NHSN Pathogen Reduced Apheresis Platelet Usage	active	2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.10.20.5.9.50	NHSNGenotypicTestInterpretation	active	2024-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.10.20.5.9.6	HealthcarePersonnelType	active	2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.10.20.5.9.7	NHSNInfluenzaVaccinationSetting	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.10.20.5.9.8	Codes for Antimicrobial Resistance Option (ARO) Summary Data	active	2020-11	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.10.20.5.9.9	Codes for Antimicrobial Usage, Pharmacy (AUP) Summary Data	active	2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.11.20.12.1	Personal And Legal Relationship Role Type	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.11.20.9.21	AgePQ_UCUM	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.11.20.9.32	DIRDocumentTypeCodes	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.11.20.9.47	ADL Result Type	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.11.20.9.49	Residence and Accommodation Type	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.11.20.9.50	Sensory Status Problem Type	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.11.20.9.51	Healthcare Agent Qualifier	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.11.20.9.52	Encounter SCT	active	2024-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.11.20.9.56	Referral Types	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.11.20.9.62	Related Document (append/replace)	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.11.20.9.66	Patient Referral Act moodCode	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.11.20.9.68	Note Types	active	2024-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.11.20.9.69.4	Advance Healthcare Directive Categories LOINC	active	2025-04	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.13.1	NHSNEncounterTypeCode	active	2019-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.13.10	NHSNASAClassCode	active	2019-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.13.11	NHSNSpinalFusionLevelCode	active	2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.13.12	NHSNOccasionOfDetectionCode	active	2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.13.13	NHSNDrugSusceptibilityFindingCode	active	2020-04	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.13.15	NHSNDrugSusceptibilityTestsCode	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.13.16	NHSNPathogenCode	active	2023-11	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.13.17	NHSNProcedureCategoryCode	active	2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.13.19	NHSNHealthcareServiceLocationCode	active	2019-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.13.2	NHSNSpinalFusionApproachCode	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.13.20	NHSNInfectionTypeCode	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.13.3	NHSNHipReplacementCode	active	2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.13.4	NHSNKneeReplacementCode	active	2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.13.6	NHSNInfectionRiskFactorsCode	active	2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.13.7	NHSNBloodStreamInfectionEvidenceTypeCode	active	2020-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.13.9	NHSNWoundClassCode	active	2020-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.17.4077.2.1017	Closed Head and Facial Trauma	active	2020-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.17.4077.2.1018	Closed Head and Facial Trauma	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.134	Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatment	active	2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.136	Perforation of Uterus	active	2024-04	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.137	Uterine Window	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.138	Uterine Rupture	active	2024-04	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.200	Anticoagulant Therapy	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.201	Antithrombotic Therapy Anticoagulant	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.202	Atrial Fibrillation or Flutter	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.203	Atrial Ablation	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.204	Carotid Intervention	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.205	Direct Thrombin Inhibitor	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.207	Discharged to Health Care Facility for Hospice Care	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.209	Discharged to Home for Hospice Care	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.211	Injectable Factor Xa Inhibitor for VTE Prophylaxis	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.212	Hemorrhagic Stroke	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.213	INR	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.214	Intermittent pneumatic compression devices	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.215	LDLc	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.218	Unfractionated Heparin	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.219	Low Molecular Weight Heparin for VTE Prophylaxis	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.222	Intravenous route	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.223	Subcutaneous route	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.226	Thrombolytic tPA Therapy	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.230	Venous foot pumps	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.232	Warfarin	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.234	Hemorrhagic Stroke	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.235	Hemorrhagic Stroke	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.238	Carotid Intervention	active	2025-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.239	Carotid Intervention	active	2019-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.242	Atrial Ablation	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.243	Atrial Ablation	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.244	Atrial Fibrillation or Flutter	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.245	Atrial Fibrillation or Flutter	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.246	Atrial Fibrillation or Flutter	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.247	Ischemic Stroke	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.25	Single Live Birth	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.251	Ischemic Stroke Embolism	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.252	Ischemic Stroke Embolism	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.255	General Surgery	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.256	Graduated compression stockings	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.257	Gynecological Surgery	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.258	Hip Fracture Surgery	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.259	Hip Replacement Surgery	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.26	Single Live Born Newborn Born in Hospital	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.260	Intracranial Neurosurgery	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.261	Knee Replacement Surgery	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.263	Obstetrical or Pregnancy Related Conditions	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.264	Obstetrics VTE	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.27	Dietary Intake Other than Human Milk	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.270	Acute or Persistent Asthma	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.271	Acute or Persistent Asthma	active	2022-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.272	Urological Surgery	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.279	Venous Thromboembolism	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.281	Labor	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.282	Cesarean Birth	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.286	Conditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestation	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.288	Medical Induction of Labor	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.292	Emergency Department Visit	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.294	Decision to Admit to Hospital Inpatient	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.295	Decision to Admit to Hospital Inpatient	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.296	Psychiatric/Mental Health Diagnosis	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.298	Psychiatric/Mental Health Diagnosis	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.299	Psychiatric/Mental Health Diagnosis	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.30	Human Milk	active	2025-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.308	Left Against Medical Advice	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.309	Patient Expired	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.310	Gynecological Surgery	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.313	Gynecological Surgery	active	2023-01	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.315	Knee Replacement Surgery	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.317	Knee Replacement Surgery	active	2023-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.319	Hip Replacement Surgery	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.321	Hip Replacement Surgery	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.323	Hip Fracture Surgery	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.325	Hip Fracture Surgery	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.328	Venous Thromboembolism	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.33	Galactosemia	active	2024-04	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.330	Venous Thromboembolism	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.331	Urological Surgery	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.333	Urological Surgery	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.335	Obstetrical or Pregnancy Related Conditions	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.337	Obstetrical or Pregnancy Related Conditions	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.338	Obstetrics VTE	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.340	Obstetrics VTE	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.344	Intracranial Neurosurgery	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.346	Intracranial Neurosurgery	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.348	General or Neuraxial Anesthesia	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.35	Galactosemia	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.361	General Surgery	active	2021-04	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.365	General Surgery	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.367	Cesarean Birth	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.369	Cesarean Birth	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.37	Parenteral Nutrition	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.38	Parenteral Nutrition	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.384	Medical Induction of Labor	active	2024-04	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.393	Conditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestation	active	2024-04	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.395	Conditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestation	active	2025-05	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.400	Low Risk	active	2024-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.401	Delivery Procedures	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.418	Classical Cesarean Birth	active	2024-04	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.419	Classical Cesarean Birth	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.421	Classical Cesarean Birth	active	2022-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.422	Myomectomy	active	2024-04	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.423	Statin Allergen	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.424	Nonelective Inpatient Encounter	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.473	Medical Reason For Not Providing Treatment	active	2022-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.75	Neonatal Intensive Care Unit	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.76	Single Live born Newborn	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.78	Galactosemia	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.79	Parenteral Nutrition	active	2021-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.87	Discharge To Acute Care Facility	active	2021-06	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.117.1.7.1.93	Patient Refusal	active	2025-02	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1434.1047	Skin Melanoma pT1	active	2024-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.100	Injectable Fluorouracil	active	2020-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.101	Trastuzumab and Biosimilars	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.102	Breast Cancer	active	2020-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.103	HER2 Presence in Tissue	active	2020-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.104	Depression Screening for Adult	active	2020-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.105	Long Acting Opioids	active	2024-08	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.106	High Fiber Supplement or Diet Education	active	2020-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.107	Standardized Assessment Tools for Dyspnea	active	2020-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.108	Nausea or Vomiting Assessment	active	2020-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.109	Pancreatic Cancer	active	2020-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.110	Pancreatic Cancer	active	2023-07	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.111	Audio Visual Telehealth Encounter	active	2020-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.112	Telephone Encounter	active	2020-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.113	Telehealth Emergency Department or Initial Inpatient	active	2020-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.114	Karnofsky Performance Status	active	2020-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.115	Referral to Hospice Care	active	2020-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.116	Referral to Palliative Care	active	2020-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.117	Assessment Scale for Dyspnea	active	2020-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.118	Nausea or Vomiting Assessment	active	2020-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.119	Enrollment in Hospice Care	active	2020-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.120	Palliative Care	active	2020-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.121	Advance Directive Including Durable Power of Attorney or Instructional	active	2020-10	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.122	Carmustine Injectable	active	2022-09	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.123	Dacarbazine Injectable	active	2021-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.124	Streptozocin Injectable	active	2021-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.126	Alemtuzumab Injectable	active	2024-11	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.127	Azacitidine Injectable	active	2024-11	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.128	Bendamustine Injectable	active	2024-11	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.129	Busulfan Injectable	active	2021-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.130	Temozolomide Injectable	active	2021-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.131	Thiotepa Injectable	active	2021-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.132	Oxaliplatin Injectable	active	2021-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.133	Romidepsin Injectable	active	2021-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.134	Trabectedin Injectable	active	2021-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.135	Dolasetron Oral	active	2021-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.136	Dolasetron Injectable	active	2025-04	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.137	Granisetron Oral	active	2021-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.138	Granisetron Transdermal	active	2021-03	us
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.1444.3.139	Granisetron Injectable	active	2021-03	us